Pulmozyme 1 MG/ML ampul 2.5ML
Ended Awarded
- Contract number
- SPE2DR26FCJ7Z
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,168
Award facts
- Contract value 100% obligated
- $8,168.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Pulmozyme 1 mg/ml ampul 2.5ml pharmaceutical product, with a ceiling value of $8,168.13 under a firm fixed-price contract type. This delivery order represents a non-set-aside award issued to the vendor's Conshohocken, Pennsylvania location and is scheduled for ultimate completion by October 22, 2025. The contract is a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle valued through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract portfolio demonstrates extensive capability in delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for Pulmozyme, a specialty pharmaceutical used in cystic fibrosis treatment, exemplifies the company's role as a key supplier within the DLA's medical supply chain supporting military and veteran healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FCJ7Z?
SPE2DR26FCJ7Z was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 21, 2025.
How much is contract SPE2DR26FCJ7Z worth?
The government has obligated $8,168 on SPE2DR26FCJ7Z.
Is contract SPE2DR26FCJ7Z an order under another contract?
Yes. SPE2DR26FCJ7Z is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCJ7Z competed?
The extent of competition for SPE2DR26FCJ7Z was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award